With nearly 1,000 lawyers practicing in 13 offices around the globe, Arnold & Porter Kaye Scholer serves clients across 40 distinct practice areas. The combined firm, which draws upon the legacies of both Arnold & Porter and Kaye Scholer, brings together 100 years of renowned regulatory expertise, sophisticated litigation and transactional practices, and leading multidisciplinary offerings in the life sciences and financial services industries.
Arnold & Porter Kaye Scholer is a global leader in representing life sciences clients, with a unique depth and breadth of experience. For nearly seven decades, our attorneys have successfully represented a broad spectrum of life sciences clients. In fact, we actively represent approximately 39 of the world's top 50 pharmaceutical companies listed in Pharmaceutical Executive's ‘2016 Pharma 50’, handling the most complex and high-stakes matters for these clients. Specifically, Arnold & Porter Kaye Scholer has nearly 200 attorneys providing the full range of litigation, regulatory, intellectual property, and transactional services to pharmaceutical, biotechnology, medical device and diagnostic companies, individual scientist entrepreneurs, emerging growth companies, universities, non-profit institutions, and investors. Our life sciences offerings cover regulatory matters, internal investigations, civil and criminal government investigations, domestic and global compliance programmes, patent procurement, structuring and fund raising, corporate transactions, mergers and acquisitions, tax and securities offerings, licensing and other partnering transactions, patent and commercial litigation, antitrust, product liability and government contracting.